LATEST NEWSTue, 29. July 2025PROVIREX and LIV receive €1.7 million to develop gene therapy platform targeting HTLV-1
LATEST NEWSTue, 4. April 2023The new PROVIREX laboratories have been officially approved and are now ready for operation
LATEST NEWSThu, 30. March 2023Milestone in the fight against the trigger of a form of leukaemia in cooperation between TU Dresden, PROVIREX and the Friedrich Alexander University Erlangen-Nuremberg (FAU)
LATEST NEWSThu, 27. October 2022Starting signal to set up a therapy hub at Science City Hamburg Bahrenfeld
